Precision Oncology: Translating Discovery to the Clinic | EK45
Structural Basis for the Action of Clinical MEK Inhibitors at KSR-Bound MEK
Jun 21, 2021 11:40am ‐ Jun 21, 2021 12:05pm
Arvin C. Dar
, PhD, Icahn School of Medicine at Mount Sinai
You must be logged in and own this session in order to post comments.
© 2022 Keystone Symposia & Digitell, Inc. All Rights Reserved